Roland R. Griffiths, Ph.D.
Professor, Departments of Psychiatry and Neuroscience
Behavioral Pharmacology Research Unit
Johns Hopkins Bayview Medical Center
5510 Nathan Shock Drive
Baltimore, MD 21224
Phone 410-550-0034 / Fax 410-550-0030
Email: rgriff@jhmi.edu
Rebecca Debus
E-mail:rparviz@jhmi.edu
1968 | B.A. | Occidental College |
1972 | Ph.D. | University of Minnesota |
Human behavioral pharmacology of drugs of abuse, with special interest in benzodiazepines, novel anxiolytics/hypnotics, caffeine, nicotine, cocaine, and hallucinogens.
Full CV available from BPRU site.
Griffiths, R.R., Richards, W.A., McCann, U., & Jesse, R. (2006). Psilocybin can occasion mystical experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology, 187, 268-283.
Johnson, M.W., Suess, P.E., & Griffiths, R.R. (2006). Ramelteon: A Novel Hypnotic Lacking Abuse Liability and Sedative Side Effects. Archives of General Psychiatry, 63, 1149-1157.
Carter, L.P., Richards, B.D., Mintzer, M.Z., & Griffiths, R.R. (2006). Relative abuse liability of GHB in humans: a comparison of psychomotor, subjective, and cognitive effects of supratherapeutic doses of triazolam, pentobarbital, and GHB. Neuropsychopharmacology, 31, 2537-2551.
Griffiths, R.R., & Johnson, M.W. (2005). Relative abuse liability of hypnotic drugs: A conceptual framework and algorithm for differentiating among compounds. Journal of Clinical Psychiatry, 66 (suppl. 9), 31-41.
Weerts EM. Goodwin AK, Griffiths RR, Brown PR, W Froestl W, Jakobs C, Gibson KM. Spontaneious and precipitated withdrawal after chronic intragastric administration of gamma-hydroxybutyrate (GHB) in baboons. Psychopharmacology, 170: 678-687. (2005)
Sobel BX, Sigmon SC, Griffiths RR. Transdermal nicotine maintenance attenuates the subjective and reinforcing effects of intraveneous nicotine, but not cocaine or caffeine, in cigarette-smoking stimulant abusers. Neuropsychopharmacology, 29: 991-1003. (2004)
Juliano LM, Griffiths RR. A critical review of caffeine withdrawal: Empirical validation of symptoms and signs, incidence, severity, and associated features. Psychopharmacology, 176: 1-29. (2004)
Griffiths RR, Bigelow GE, Ator NA. Principles of initial experimental drug abuse liability assessment in humans. Drug and Alcohol Dependence, 70, S41-S54. (2003)
Griffiths RR, Juliano LM, Chausmer AL. Caffeine pharmacology and clinical effects. In: Graham AW, Schultz TK, Mayo-Smith MF, Ries RK & Wilford BB (eds.) Principles of Addiction Medicine, Third Edition (pp. 193-224). Chevy Chase, MD: American Society of Addiction. (2003)
